CASP3 and neoplasm: The suppression of caspase 3, 7, and 9 activation favours tumour growth and also strengthens the resistance of tumour cells against the effects of cisplatin-based chemotherapy in advanced oral SCCs and oesophageal SCCs [25, 26].